The U.S.-Israel rift widens over Prime Minister Netanyahu's stance on Iran. Russia threatens to cut off gas supplies to Ukraine and Western Europe. And "Jihadi John" has been identified as a British national. A panel of journalists joins Diane for analysis of the week's top international news stories.
Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Gardiner Harris science reporter for "The New York Times"
Most Recent Shows
The clock is ticking as Congress races to fund the Department of Homeland Security. The House of Representatives considers a short-term funding bill to buy time before tonight’s midnight deadline. And in an historic vote, the Federal Communications Commission classifies broadband internet service as a public utility. A panel of journalists joins Diane for analysis of the week's top national news stories.
Tens of millions of Americans take nutritional supplements. New studies allege some pills do not contain what is on the label. Other research indicates consumers may be ingesting too many vitamins. New concerns about dietary supplements.
The next chapter in the battle over net neutrality: An expected new ruling from the FCC to regulate the Internet as a public utility.